Etelcalcetide, sold under the brand name Parsabiv, is a calcimimetic medication for the treatment of secondary hyperparathyroidism in people undergoing...
11 KB (735 words) - 06:16, 1 July 2024
calcimimetic, etelcalcetide (formerly velcalcetide), for the treatment of SHPT in chronic kidney disease (CKD) patients on hemodialysis. Etelcalcetide is administered...
3 KB (319 words) - 11:15, 17 June 2024
H05BX01 Cinacalcet H05BX02 Paricalcitol H05BX03 Doxercalciferol H05BX04 Etelcalcetide H05BX05 Calcifediol H05BX06 Evocalcet "ATC (Anatomical Therapeutic Chemical...
906 bytes (209 words) - 04:50, 18 December 2023
In July, Amgen acquired KAI Pharmaceuticals, developer of Parsabiv (etelcalcetide). Amgen acquired Iceland-based deCODE Genetics in December. 2013: In...
96 KB (7,734 words) - 13:14, 22 July 2024
Lanreotide (Somatuline), Plecanatide (Trulance), Ximelagatran (Exanta), Etelcalcetide (Parsabiv), and Bortezomib (Velcade). Peptidomimetic approaches have...
12 KB (1,365 words) - 13:34, 2 July 2024
Gamma-Glutamyl peptides L- amino acids Cinacalcet Evocalcet NPS R-568 NPS R-467 Etelcalcetide Calhex 231 Calcilytics Phosphate NPS 2143 Ronacaleret Calhex 231 It...
32 KB (3,840 words) - 08:06, 9 August 2024